Skip to main content
. 2012 Apr 18;2012(4):CD003869. doi: 10.1002/14651858.CD003869.pub3

Graham 2010

Methods RCT:
evaluated: 113
Participants ECOG performance status <3
life expectancy > 2 months
extracranial disease (stable for 2 months, or absent or concurrent with brain metastases at time of initial cancer diagnosis)
Interventions whole brain radiotherapy 40 Gy in 20 twice daily fractions
versus
whole brain radiotherapy 20 Gy in 4 daily fractions
Outcomes primary:
intracranial control and quality of life
secondary:
interval to CNS progression
overall survival
Notes